PKC and MEK pathways inhibit caspase-9/-3-mediated cytotoxicity in differentiated cells
Abstract
Many studies have indicated that differentiated cells inhibit drug-induced cytotoxicity but undifferentiated cells do not, though the mechanisms are unclear. Currently, HL-60 cells are induced to differentiate into macrophage-like cells with Phorbol-12-myristate-13-acetate (TPA) treatment (TPA-differentiated cells). Our study shows that caspase-9/-3-mediated cytotoxicity can be induced in undifferentiated HL-60 cells but not in TPA-differentiated HL-60 cells. However, caspase-9/-3-mediated cytotoxicity can be induced in TPA-differentiated cells if they are pretreated with a protein kinase C (PKC) or a mitogen activated protein kinase (MEK) inhibitor. Taken together, this study demonstrates that TPA-differentiated HL-60 cells inhibit caspases-9/-3-mediated cytotoxicity through the PKC and MEK signaling pathways.
Keywords: Caspases, PKC, MEK, Differentiation
To access this article, please choose from the options below
PII: S0014-5793(08)00123-3
doi:10.1016/j.febslet.2008.02.018
© 2008 Federation of European Biochemical Societies
